Hans Biomed (XKRX:042520) Debt-to-Asset : 0.31 (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Debt-to-Asset?

Hans Biomed's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩35,455 Mil. Hans Biomed's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩943 Mil. Hans Biomed's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩119,004 Mil. Hans Biomed's debt to asset for the quarter that ended in Dec. 2024 was 0.31.

Hans Biomed Debt-to-Asset Historical Data

The historical data trend for Hans Biomed's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Debt-to-Asset Chart

Hans Biomed Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Debt-to-Asset

Get a 7-Day Free Trial

0.25

0.40

0.43

0.34

0.30

Hans Biomed Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.24	0.26	0.27	0.30	0.31

Competitive Comparison of Hans Biomed's Debt-to-Asset

For the Medical Devices subindustry, Hans Biomed's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hans Biomed's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Hans Biomed's Debt-to-Asset falls into.

Hans Biomed Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Hans Biomed's Debt-to-Asset for the fiscal year that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(35429.768	+	1000.013)	/	121715.44
	=	0.30

Hans Biomed's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(35454.857	+	943.478)	/	119003.662
	=	0.31

Hans Biomed (XKRX:042520) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Hans Biomed Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hans Biomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Jeong-i-ro 8-gil, Songpa-gu, Seoul, KOR

Website

http://www.hansbiomed.com

Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.

Hans Biomed Headlines

No Headlines